Peptides for the treatment of herpes virus infections

Details Peptides for the treatment of herpes virus infections Peptides for the treatment of herpes virus infections

2005-08-16

2010-06-22

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07741287

ABSTRACT:
The present invention relates to the use of a peptide having the amino acid sequence NH2-VCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH-COOH (SEQ ID NO:1) as well as variants, derivatives and fragments of the peptide for the treatment of viral diseases.

REFERENCES:
patent: 5861483 (1999-01-01), Wolpe
patent: 5922854 (1999-07-01), Kumar et al.
patent: 6022848 (2000-02-01), Kozlov et al.
patent: 6171826 (2001-01-01), Levine et al.
patent: 6337314 (2002-01-01), Hoffman et al.
patent: 2003/0104984 (2003-06-01), Tsyrlova et al.
patent: 1 481 988 (2004-12-01), None
patent: 2 382 347 (2003-05-01), None
patent: 01 009997 (1989-01-01), None
patent: WO 01/94386 (2001-12-01), None

Affiliated with

Also associated with

Rating

Peptides for the treatment of herpes virus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for the treatment of herpes virus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for the treatment of herpes virus infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4160760